These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9368472)

  • 1. [Reconsideration of the therapy of coronary heart disease is needed. Symposium: "Prevention and Treatment of Coronary Disease", part of the 103rd Congress of the German Society of Internal Medicine. Wiesbaden, 6 April 1997].
    Dtsch Med Wochenschr; 1997 Oct; 122(42 Suppl Umdenken):1-4. PubMed ID: 9368472
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A
    Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug treatment for hypercholesterolaemia.
    Ball MJ; Mann JI
    Q J Med; 1986 Aug; 60(232):733-5. PubMed ID: 3774956
    [No Abstract]   [Full Text] [Related]  

  • 5. [4S [Scandinavian Simvastatin Survival Study]].
    Koizumi J; Yoshida I
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():410-5. PubMed ID: 11347105
    [No Abstract]   [Full Text] [Related]  

  • 6. Attaining United States and European guideline LDL-C levels with simvastatin in patients with coronary heart disease (the GOALLS study).
    Mikhailidis DP; Wierzbicki AS
    Curr Med Res Opin; 2000; 16(3):205-7. PubMed ID: 11191011
    [No Abstract]   [Full Text] [Related]  

  • 7. The statin trials: closing arguments in the case against cholesterol?
    Gaw A
    Scott Med J; 1996 Aug; 41(4):99-100. PubMed ID: 8873306
    [No Abstract]   [Full Text] [Related]  

  • 8. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
    Lim PO; Yee KM
    Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes and residual risk of coronary heart disease.
    Nesto RW; Singh PP
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):71. PubMed ID: 17237830
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug therapy for coronary heart disease: the Sheffield table.
    Wallis EJ; Ramsay LE; Jackson PR; Yeo WW; Williamson R
    Lancet; 1997 Dec 20-27; 350(9094):1852. PubMed ID: 9428275
    [No Abstract]   [Full Text] [Related]  

  • 11. [New combination therapy. Up to 60% lower LDL cholesterol level].
    MMW Fortschr Med; 2004 May; 146(19):63. PubMed ID: 15357489
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary and secondary prevention of coronary heart disease. Evidence offers multiple strategies.
    Lynn MM
    Adv Nurse Pract; 2000 Jun; 8(6):36-41; quiz 42-3. PubMed ID: 15658206
    [No Abstract]   [Full Text] [Related]  

  • 13. What do the statin trials tell us?
    Waters DD
    Am J Manag Care; 2001 May; 7(5 Suppl):S138-43. PubMed ID: 11383375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 15. How effective is simvastatin 10 mg?
    Young J
    Br J Gen Pract; 2003 Apr; 53(489):326-7. PubMed ID: 12879839
    [No Abstract]   [Full Text] [Related]  

  • 16. In patients with heart disease, is the benefit of lipid-lowering therapy with statins similar in older patients to that in younger patients?
    Adelman A
    J Fam Pract; 2001 Nov; 50(11):924. PubMed ID: 11711002
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipoproteins and coronary heart disease.
    Krauss RM
    Postgrad Med; 1989 Apr; Spec No():54-8; discussion 89-90. PubMed ID: 2726627
    [No Abstract]   [Full Text] [Related]  

  • 18. Introduction: missing the target with lipid-lowering therapy.
    Hunninghake DB; McKenney JM
    Am J Manag Care; 2000 Nov; 6(19 Suppl):S992-6. PubMed ID: 11187370
    [No Abstract]   [Full Text] [Related]  

  • 19. [Commentary: External validity of studies on Primary Care prevention of Hypercholesterolemia].
    Brotons C
    Aten Primaria; 2003 Nov; 32(9):514-6. PubMed ID: 14651828
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
    Foody JM; Brown WV; Zieve F; Adewale AJ; Flaim D; Lowe RS; Jones-Burton C; Tershakovec AM
    Am J Cardiol; 2010 Nov; 106(9):1255-63. PubMed ID: 21029821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.